Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while...

from NDTV News - Topstories https://ift.tt/35BsWI9

https://ift.tt/2PmHCzA